rs4908273
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001854.4(COL11A1):c.3816+58G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.117 in 1,415,680 control chromosomes in the GnomAD database, including 10,764 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.11 ( 1098 hom., cov: 32)
Exomes 𝑓: 0.12 ( 9666 hom. )
Consequence
COL11A1
NM_001854.4 intron
NM_001854.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.374
Publications
8 publications found
Genes affected
COL11A1 (HGNC:2186): (collagen type XI alpha 1 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Mutations in this gene are associated with type II Stickler syndrome and with Marshall syndrome. A single-nucleotide polymorphism in this gene is also associated with susceptibility to lumbar disc herniation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
COL11A1 Gene-Disease associations (from GenCC):
- Marshall syndromeInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- Stickler syndrome type 2Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, PanelApp Australia, Orphanet, Genomics England PanelApp
- fibrochondrogenesis 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- hearing loss, autosomal dominant 37Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- fibrochondrogenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive Stickler syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 1-102915573-C-T is Benign according to our data. Variant chr1-102915573-C-T is described in ClinVar as Benign. ClinVar VariationId is 1221542.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.204 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.115 AC: 17465AN: 151976Hom.: 1096 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
17465
AN:
151976
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.117 AC: 147837AN: 1263586Hom.: 9666 AF XY: 0.118 AC XY: 75623AN XY: 639404 show subpopulations
GnomAD4 exome
AF:
AC:
147837
AN:
1263586
Hom.:
AF XY:
AC XY:
75623
AN XY:
639404
show subpopulations
African (AFR)
AF:
AC:
4099
AN:
29564
American (AMR)
AF:
AC:
4219
AN:
44446
Ashkenazi Jewish (ASJ)
AF:
AC:
1754
AN:
24896
East Asian (EAS)
AF:
AC:
9820
AN:
38684
South Asian (SAS)
AF:
AC:
14676
AN:
82316
European-Finnish (FIN)
AF:
AC:
3082
AN:
53292
Middle Eastern (MID)
AF:
AC:
478
AN:
5404
European-Non Finnish (NFE)
AF:
AC:
103672
AN:
931178
Other (OTH)
AF:
AC:
6037
AN:
53806
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
6407
12815
19222
25630
32037
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3678
7356
11034
14712
18390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.115 AC: 17470AN: 152094Hom.: 1098 Cov.: 32 AF XY: 0.113 AC XY: 8386AN XY: 74364 show subpopulations
GnomAD4 genome
AF:
AC:
17470
AN:
152094
Hom.:
Cov.:
32
AF XY:
AC XY:
8386
AN XY:
74364
show subpopulations
African (AFR)
AF:
AC:
5612
AN:
41474
American (AMR)
AF:
AC:
1351
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
240
AN:
3468
East Asian (EAS)
AF:
AC:
1103
AN:
5152
South Asian (SAS)
AF:
AC:
954
AN:
4830
European-Finnish (FIN)
AF:
AC:
521
AN:
10602
Middle Eastern (MID)
AF:
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7411
AN:
67972
Other (OTH)
AF:
AC:
222
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
782
1563
2345
3126
3908
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
206
412
618
824
1030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
703
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.